Serum Anti-oksidan Vitamin Levels in Children and Adolescents with Attention Deficit Hyperactivity Disorder
PDF
Cite
Share
Request
Original Article
P: 103-107
November 2019

Serum Anti-oksidan Vitamin Levels in Children and Adolescents with Attention Deficit Hyperactivity Disorder

Turk J Child Adolesc Ment Health 2019;26(3):103-107
1. Mersin Şehir Eğitim ve Araştırma Hastanesi, Çocuk ve Ergen Psikiyatrisi Kliniği, Mersin, Türkiye
2. Sağlık Bilimleri Üniversitesi Antalya Eğitim ve Araştırma Hastanesi, Çocuk ve Ergen Psikiyatrisi Kliniği, Antalya, Türkiye
3. Hacettepe Üniversitesi Tıp Fakültesi, Beslenme ve Metabolizma Laboratuvarı, Ankara, Türkiye
4. Hacettepe Üniversitesi Tıp Fakültesi, Çocuk ve Ergen Ruh Sağlığı Anabilim Dalı, Ankara, Türkiye
No information available.
No information available
Received Date: 18.07.2013
Accepted Date: 09.06.2017
Publish Date: 21.11.2019
PDF
Cite
Share
Request

ABSTRACT

Objectives:

The etiological causes of attention deficit and hyperactivity disorder (ADHD) are not fully understood yet. Recent studies have reported that the anti-oxidant activity is reduced and the oxidative stress is increased in ADHD. The aim of this study is to compare serum antioxidant vitamin levels, which are important components of anti-oxidant defense system, between the children and adolescents with ADHD and healthy controls.

Materials and Methods:

Serum levels of vitamin A, C and E were compared between 39 children and adolescents diagnosed with ADHD and 25 healthy controls with similar age and gender by using clinical evaluation and rating scales.

Results:

There were no significant differences in serum vitamin A,C and E levels between ADHD and control groups.

Conclusion:

This study concludes no significant effect of serum A, C and E vitamin levels on ADHD. There is still need for future studies on larger samples.

References

1
Barry Halliwell. Antioxidant defence mechanisms: From the beginning to the end (of the beginning). Free Radical Research. 1999;31:261-272.
2
Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology. 2000;7:153-163.
3
Haddad JJ. Oxygen sensing and oxidant/redox-related pathways. Biochemical and Biophysical Research Communications. 2004;316:969-977.
4
Zoroğlu SS, Herken H, Yurekli M, Uz E, Tutkun H, Savaş HA, Bagci C, Ozen ME, Cengiz B, Cakmak EA, Dogru MI, Akyol O. The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia. Journal of Psychiatric Research. 2002;36:309-315.
5
Paşca SP, Nemes B, Vlase L, Gagyi CE, Dronca E, Miu AC, Dronca M. High levels of homocysteine and low serum paraoxonase 1arylesterase activity in children with autism. Life Sciences. 2006;78:2244-2248.
6
Ceylan MF, Şener S, Bayraktar AC ve ark. Changes in oxidative stress and cellular immunity serum markers in attention-deficit/hyperactivity disorder. Psychiatry Clin Neurosci. 2012;66:220-226.
7
Ceylan M, Sener S, Bayraktar AS ve ark. Oxidative imbalance in child and adolescent patients with attention-deficit/ hyperactivity disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2010;34:1491-1494.
8
Can M, Güven B, Atik L, Konuk N. Lipid peroxidation and serum antioxidant enzymes activity in patients with bipolar and major depressive disorders. Journal of Mood Disorders 2011;1:14-18.
9
Nasim S, Naeini AA, Najafi M ve ark. Relationship between antioxidant status and attention deficit hyperactivity disorder among children. Int J Prev Med. 2019;10:41.
10
Felicity Ng, Michael Berk, Olivia Dean, Ashley I. Bush, Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. International Journal of Neuropsychopharmacology. 2008;11:851-876
11
Selek S, Bulut M, Ocak AR, Kalenderoglu A, Savas H. Evaluation of total oxidative status in adult attention deficit hyperactivity disorder and its diagnostic implications. J Psychiatr Res 2012;46:451-455.
12
Yorbık O, Cansever A, Söhmen T. Otizmde nörönal görüşler. Çocuk ve Gençlik Ruh Sağlığı Dergisi. 2002;9:118-127.
13
Mahadik SP, Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia:a review. Schizophrenia Res . 1996;19:1-17.
14
Reddy RD, Yao JK. Free radical pathology in schizophrenia:a review. Prostaglandins Leukot Essent Fatty Acids. 1996;55:33-43.
15
Sencer E ve Orhan Y. Vitaminler. “Klinik Beslenme” 1. baskı içinde. Sencer E ve Orhan Y (ed). Çapa-istanbul: İstanbul Medikal Yayıncılık. 2005;s:166-187.
16
Sies H, Stahl W, Sundquist AR. Antioxidants function of vitamins E and C, beta carotene and other carotenoids. Ann NY Acad Sci. 1992;30:7-20.
17
Rao AV, Ray MR, Rao LG. Lycopene. Adv Food Nutr Res. 2006;51:99-164.
18
O’Reilly KC, Trent S, Bailey SJ, Lane MA. 13-cis-retinoic acid alters intracellular serotonin, increases 5-HT1A receptor, and serotonin reuptake transporter levels in vitro. Exp Biol Med (Maywood) 2007;232:1195-1203.
19
Cocco S, Diaz G, Stancampiano R, Diana A, Carta M, Curreli R et al. Vitamin A deficiency produces spatial learning and memory impairment in rats. Neuroscience. 2002;115:475-482.
20
Rice ME. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 2000;23:209-216.
21
Takada T, Suzuki H. Molecular mechanisms of membrane transport of vitamin E. Mol Nutr Food Res. 2010;54:616-622.
22
Gökler B, Ünal F, Pehlivantürk B, Çengel Kültür SE, Akdemir D, Taner Y. Okul çağı çocukları için duygulanım bozuklukları ve şizofreni görüşe çizelgesi şimdi ve yaşam boyu versiyonu - Türkçe versiyonu’nun (ÇDSG-SY-T) geçerlilik ve güvenirliği. Çocuk ve Gençlik Ruh Sağlığı Dergisi. 2004; 11:109-116.
23
Dereboy Ç, Şenol S, Şener Ş, Dereboy F. Conners Kısa Form Öğretmen ve Ana Baba Derecelendirme Ölçeklerinin Geçerliği. Türk Psikiyatri Dergisi. 2007;18:48-58.
24
Turgay, A. Çocuk ve ergenlerde davranım bozuklukları için DSM-IV’e dayalı tarama ve değerlendirme ölçeği (Yayınlanmış Ölçek). Integrative Therapy Institute,Toronto : Kanada. 1995
25
Hollingshead AB, Redlich F C. Social class and mental illness: A community study. New York: Wiley. 1958.
26
Landaas ET, Aarsland TIM, Ulvik A ve ark.Vitamin levels in adults with ADHD. BJPsych Open. 2016;2:377-384
27
Guo M, Zhu J, Yang T ve ark. Vitamin A and vitamin D deficiencies exacerbate symptoms in children with autism spectrum disorders. Nutritional Neuroscience. 2018;16:1-11.
28
Bakkaloğlu B . Otistik bozuklukta antioksidan enzim ve antioksidan vitamin düzeyleri, malondialdehit ve glutatyon düzeyleri (Uzmanlık tezi). Ankara, Hacettepe Üniversitesi. 2007
29
Al-Gadani Y, El-Ansary A, Attas O ve ark. Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin Biochem. 2009;42:1032-1040.
30
Derin D, Yazıcı A, Erkoç Ş. Şizofrenik bozukluğu olan hastalarda serbest radikal metabolizması ve nonenzimatik antioksidan savunma sistemi elemanlarının incelenmesi. Klinik Psikofarmakoloji Bülteni. 2001;11:174-182.
31
Dadheech G, Mishra S, Gautam S ve ark. Oxidative stress, a-tocopherol, ascorbic acid and reduced glutathione status in schizophrenics. Indian J Clin Biochem. 2006;21:34-38.
32
Kılıçgün H, Erşan EE, Bakır S, ve ark. Xanthine oxidase, adenosine deaminase and vitamin E levels in patients with schizophrenia. Anadolu Psikiyatri Dergisi. 2016;17:476-481.
33
Guatam M, Agrawal M, Guatam M ve ark. Role of antioxidants in generalised anxiety disorder and depression. Indıan J Psychiatry. 2012;54:244-247.
34
Mazlum B. Antioksidan Vitaminler ve Psikiyatride Kullanımı. Psikiyatride Güncel Yaklaşımlar-Current Approaches in Psychiatry. 2012;4:486-505.
35
Dolske MC, Spollen J, McKay S ve ark. A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog Neuropsychopharmacol Biol Psychiatry. 1993;17:765-774.
36
Dakhale GN, Khanzode SD, Khanzode SS ve ark. Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia. Psychopharmacology (Berl). 2005;182:494-498.
37
Sivrioglu EY, Kirli S, Sipahioglu D ve ark. The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1493-1499.
38
Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr Res. 2003;62:195-204.
39
Green WH. The treatment of attention deficit hyperactivity disorder with nonstimulant medications. Child Adolesc Psychiatric Clin North Am. 1995;4:169-195.
40
Joshi K, Lad S, Kalea M ve ark. Supplementation with flax oil and vitamin C improves the outcome of attention deficit hyperactivity disorder. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2006;74:17-21.
41
Gelain DP, Bittencourt Pasquali MA, Caregnato FF, Moreira JC. Vitamin A (retinol) up-regulates the receptor for advanced glycation endproducts (RAGE) through p38 and Akt oxidant-dependent activation. Toxicology. 2011;289:38-44.
42
Buettner GR, Jurkiewicz BA. Cataliytic metals, ascorbate and free radicals: combinations to avoid. Radiat Res. 1996;145:532-541.
43
Kimmoun A, Leheup B, Feillet F, Dubois F, Morali A. Hypercalcemia revealing iatrogenic hypervitaminosis A in a child with autistic troubles. Arch Pediatr. 2008;15:29-32.
44
Shulman RG, Rothman DL, Behar KL ve ark. Energetic basis of brain activity:implications for neuroimaging. Trends Neurosci. 2004;27:489-495.
45
Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology. 2006;13:171-181.